ArticleMaterials today. Bio2026

CXCR4 antagonistic lipid nanoparticles loading siRNA combat refractory AML through AML1-ETO depletion and homoharringtonine sensitization.

Xuelu Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.